Autologous transplantation of shock wave-treated bone marrow-derived mononuclear cells enhances vascularization and connexin43 expression in rat dilated cardiomyopathy

Acta Cardiologica Sinica

Volumn 25, Issue 2, 2009, Pages 64-75

  Chua, Sarah ^a   Sun, Cheuk Kwan ^a   Yen, Chia Hung ^b   Ko, Sheung Fat ^a   Chang, Li Teh ^a   Sheu, Jiunn Jye ^c   Wu, Chiung Jen ^a   Fu, Morgan ^a   Wang, Ching Jen ^a   Yip, Hon Kan ^a,d  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c MEIHO UNIVERSITY   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Bone marrow stem cell therapy; Dilated cardiomyopathy; Shock wave therapy

Indexed keywords

CASPASE 3; CONNEXIN 43; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; GELATINASE B; INTERLEUKIN 10; MESSENGER RNA; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW; CONGESTIVE CARDIOMYOPATHY; CONTROL GROUP; CONTROLLED STUDY; EUTHANASIA; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBROSIS; IMPLANT; MALE; MITOCHONDRION; MONONUCLEAR CELL; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; SHOCK WAVE; SPRAGUE DAWLEY RAT; VASCULAR SURGERY; VASCULARIZATION;

EID: 70349127686     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Codd MB, Sugrue DD, Gersh BJ, Melton LJ. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy: A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation 1989;80:564-572
2. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1995;332:1384-1386
3. Manolio TA, Baughman KL, Rodeheffer R. Prevalence and etiology of dilated cardiomyopathy. Am J Cardiol 1992;69:1458-1466
4. Dec GW, Fuster V. Medical progress: idiopathic dilated cardiomyopathy. N Engl J Med 1994;331:1564-1575
5. Parodi O, De Maria R, Oltrona L. Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation. Circulation 1993;88:509-522 (Pubitemid 23228050)
6. Skalidis EI, Hamilos MI, Chlouverakis G, et al. Acute effect of esmolol intravenously on coronary microcirculation in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 2007;100:1299-1302 (Pubitemid 47500159)
7. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE inhibitor trials. JAMA 1995;273:1450-1456
8. Rakar S, Sinagra G, Di Lenarda A, et al. Epidemiology of dilated cardiomyopathy: a prospective post-mortem study of 5252 necropsies. Eur Heart J 1997;18:117-123 (Pubitemid 27105779)
9. Nikolaidis LA, Doverspike A, Huerbin R, et al. Angiotensin-Converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism. Circulation 2002; 105; 2785-2790 (Pubitemid 34615152)
10. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991;325:293-302.
11. Dandel M, Weng Y, Siniawski H, et al. Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation 2005;112(suppl):I-37-45.
12. Chen SM, Chen MC, Tang WHW. Improving care for patients with heart failure: what can taiwan accomplish? Acta Cardiol Sin 2007;23:211-224
13. Tomita S, Ki RK, Weisel RD, et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999;100(suppl II):II-247-256
14. Strauer BE, Brehm M, Zeus T. Repair of infarcted myocardium by autologous intracoronary mononuclear bone cell transplantation in humans. Circulation 2002;106:1913-1918 (Pubitemid 35176294)
15. Tse HF, Kwong YL, Chan JKF, et al. Angiogenesis in ischemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003;4:47-49 (Pubitemid 36050963)
16. Davani S, Marandin A, Merisin N. Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 2003;108(suppl II):II-253-258 (Pubitemid 37099964)
17. Nagaya N, Kangawa K, Itoh T. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 2005;112:1128-1135 (Pubitemid 41216119)
18. Kirchhoff S, Nelles E, Hagendorff A, et al. Reduced cardiac conduction velocity and predisposition to arrhythmias in connexin40-deficient mice. Curr Biol 1998;8:299-302. (Pubitemid 28111463)
19. Lerner DL, Yamada KA, Schuessler RB, Saffitz JE. Accelerated onset and increased incidence of ventricular arrhythmias induced by ischemia in Cx43-deficient mice. Circulation 2000;101:547-52.
20. Peters NS, Green CR, Poole-Wilson PA, Severs NJ. Cardiac arrhythmogenesis and the gap junction. J Mol Cell Cardiol 1995;27:37-44.
21. Singal PK, Khaper N, Palace V, et al. The role of oxidative stress in the genesis of heart disease. Cardiovasc Res 1998;40:426-432 (Pubitemid 28557280)
22. Ide T, Tsutsui H, Kinugawa S. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res 1999;85:357-363 (Pubitemid 29398868)
23. Ichihara S, Yamada Y, Ichihara G. Attenuation of oxidative stress and cardiac dysfunction by bisoprolol in an animal model of dilated cardiomyopathy. Biochem Biophys Res Commun 2006;350:105-113 (Pubitemid 44466579)
24. Tsutamoto T, Wada A, Matsumoto T, et al. Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy. J Am Coll Cardiol 2001;37:2086-2092 (Pubitemid 32548002)
25. Thum T, Bauersachs J, Poole-Wilson PA, et al. The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol 2005;46:1799-1802 (Pubitemid 41579799)
26. Nishida T, Shimokawa H, Oi K. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemic-induced myocardial dysfunction in pigs in vivo. Circulation 2004;110:3055-3061 (Pubitemid 39491998)
27. Gutersohn A, Caspari G. Shock waves upregulate vascular endothelial growth factor m-RNA in human umbilical vascular endothelial cells. Circulation 2000;102(suppl):18.
28. Yip HK, Chang LT, Sun CK, et al. Shock wave therapy applied to rat bone marrow-derived mononuclear cells enhance formation of cells stained positive for CD31 and vascular endothelial growth factor. Circ J 2008;72:150-156
29. Kodama M, Zhang S, Hanawa H. Effects of 15-deoxysperqualin on experimental autoimmune giant cell myocarditis of the rat. Circulation 1995;91:1116-1122
30. Watanabe K, Ohta Y, Nakazawa M. Low dose carvedilol inhibits progression of heart failure in rat with dilated cardiomyopathy. Br J Pharmacol 2000;130:1489-1495 (Pubitemid 30611923)
31. Sun, CK, Chang LT, Sheu JJ, et al. Losartan preserves integrity of cardiac gap junctions and PGC-1α gene expression and prevents cellular apoptosis in remote area of left ventricular myocardium following acute myocardial infarction. Int Heart J 2007;48:533-546
32. Yip HK, Chang LT, Wu CJ, et al. Autologous bone marrow-derived mononuclear cell therapy prevents the damage of viable myocardium and improves rat heart function following acute anterior myocardial infarction. Circ J 2008;72:1336-1345
33. Mangi AA, Noiseux N, Kong D, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infracted hearts. Nat Med 2003;9:1195-1201 (Pubitemid 37173705)
34. Jackson KA, Majka SM, Wang H. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001;107:1395-1402 (Pubitemid 32522033)
35. Quaini F, Urbanek K, Beltrami AP, Finato N. Chimerism of the transplanted heart. N Engl J Med 2002;346:5-15.
36. Dai W, Hale SL, Martin BJ, et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 2005;112:214-223 (Pubitemid 40982304)
37. Albert CJ, Ford DA. Protein kinase C translocation and PKC-dependent protein phosphorylation during myocardial ischemia. Am J Physiol Heart Circ Physiol 1999;276:H642-50.
38. Inagaki K, Hahn HS, Dorn II GW, Mochly-Roden D. Additive protection of the ischemic heart ex vivo by combined treatment with δ-protein kinase C inhibitor and ε-protein kinase C activator. Circulation 2003;108:869-875 (Pubitemid 37022131)
39. Baines CP, Zhang J, Wang GW, et al. Mitochondrial PKCε and MAPK form signaling modulates in the murine heart: enhanced mitochondrial PKCε-MAPK interactions and differential MAPK activation in PKCε-induced cardioprotection. Circ Res 2002;90:390-397 (Pubitemid 34633907)
40. Jalife J, Morley GE, Vaidya D. Connexins and impulse propagation in the mouse heart. J Cardiovasc Electrophysiol 1999;10:1649-1663 (Pubitemid 30020503)
41. Vozzi C, Dupont E, Coppen SR, et al. Chamber-related differences in connexin expression in human heart. J Mol Cell Cardiol 1999;31:991-1003. (Pubitemid 29241535)
42. Severs NJ, Rothery S, Dupont E, et al. Immunocytochemical analysis of connexin expression in healthy and diseased cardiovascular system. Microsc Res Tech 2001;52:301-322 (Pubitemid 32140399)